155 related articles for article (PubMed ID: 31485918)
1. Fast-Acting Insulin Aspart: The Rationale for a New Mealtime Insulin.
Evans M; Wilkinson M; Giannpolou A
Diabetes Ther; 2019 Oct; 10(5):1793-1800. PubMed ID: 31485918
[TBL] [Abstract][Full Text] [Related]
2. Fast-Acting Insulin Aspart and the Need for New Mealtime Insulin Analogues in Adults With Type 1 and Type 2 Diabetes: A Canadian Perspective.
Senior P; Hramiak I
Can J Diabetes; 2019 Oct; 43(7):515-523. PubMed ID: 30872107
[TBL] [Abstract][Full Text] [Related]
3. [Faster aspart insulin (FIASP®)].
Paquot N; Scheen AJ
Rev Med Liege; 2018 Apr; 73(4):211-215. PubMed ID: 29676875
[TBL] [Abstract][Full Text] [Related]
4. The continuing quest for better subcutaneously administered prandial insulins: a review of recent developments and potential clinical implications.
Owens DR; Bolli GB
Diabetes Obes Metab; 2020 May; 22(5):743-754. PubMed ID: 31930670
[TBL] [Abstract][Full Text] [Related]
5. Effective Overall Glycaemic Control with Fast-Acting Insulin Aspart Across Patients with Different Baseline Characteristics: A Post Hoc Analysis of the Onset 9 Trial.
Lane W; Favaro E; Jódar E; Kelkar P; Oviedo A; Sivarathinasami R; Senior PA; Sesti G; Franek E
Diabetes Ther; 2022 Apr; 13(4):761-774. PubMed ID: 35290624
[TBL] [Abstract][Full Text] [Related]
6. Reducing hypoglycaemia with insulin analogues.
Heller S
Int J Obes Relat Metab Disord; 2002 Sep; 26 Suppl 3():S31-6. PubMed ID: 12174321
[TBL] [Abstract][Full Text] [Related]
7. What is the value of faster acting prandial insulin? Focus on ultra rapid lispro.
Heise T; Piras de Oliveira C; Juneja R; Ribeiro A; Chigutsa F; Blevins T
Diabetes Obes Metab; 2022 Sep; 24(9):1689-1701. PubMed ID: 35593434
[TBL] [Abstract][Full Text] [Related]
8. [Faster Insulin Aspart - a new prandial insulin analogue].
Flekač M
Vnitr Lek; 2017; 63(10):697-702. PubMed ID: 29127752
[TBL] [Abstract][Full Text] [Related]
9. Insulin degludec and insulin aspart: novel insulins for the management of diabetes mellitus.
Atkin S; Javed Z; Fulcher G
Ther Adv Chronic Dis; 2015 Nov; 6(6):375-88. PubMed ID: 26568812
[TBL] [Abstract][Full Text] [Related]
10. Role of ultrafast-acting insulin analogues in the management of diabetes.
Kruger DF; Novak LM
J Am Assoc Nurse Pract; 2019 Sep; 31(9):537-548. PubMed ID: 31385938
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological Properties of Faster-Acting Insulin Aspart.
Biester T; Kordonouri O; Danne T
Curr Diab Rep; 2017 Sep; 17(11):101. PubMed ID: 28940145
[TBL] [Abstract][Full Text] [Related]
12. A Pooled Analysis of Clinical Pharmacology Trials Investigating the Pharmacokinetic and Pharmacodynamic Characteristics of Fast-Acting Insulin Aspart in Adults with Type 1 Diabetes.
Heise T; Pieber TR; Danne T; Erichsen L; Haahr H
Clin Pharmacokinet; 2017 May; 56(5):551-559. PubMed ID: 28205039
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and Safety of Fast-Acting Insulin Aspart in People with Type 1 Diabetes Using Carbohydrate Counting: A Post Hoc Analysis of Two Randomised Controlled Trials.
Rose L; Kadowaki T; Pieber TR; Buchholtz K; Ekelund M; Gorst-Rasmussen A; Philis-Tsimikas A
Diabetes Ther; 2019 Jun; 10(3):1029-1041. PubMed ID: 30949906
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic and Pharmacodynamic Properties of Faster-Acting Insulin Aspart versus Insulin Aspart Across a Clinically Relevant Dose Range in Subjects with Type 1 Diabetes Mellitus.
Heise T; Stender-Petersen K; Hövelmann U; Jacobsen JB; Nosek L; Zijlstra E; Haahr H
Clin Pharmacokinet; 2017 Jun; 56(6):649-660. PubMed ID: 27878566
[TBL] [Abstract][Full Text] [Related]
15. Faster-acting insulin aspart provides faster onset and greater early exposure vs insulin aspart in children and adolescents with type 1 diabetes mellitus.
Fath M; Danne T; Biester T; Erichsen L; Kordonouri O; Haahr H
Pediatr Diabetes; 2017 Dec; 18(8):903-910. PubMed ID: 28165180
[TBL] [Abstract][Full Text] [Related]
16. IDegAsp (insulin degludec + insulin aspart) for the management of type 2 diabetes: current status.
Christiansen JS; Home P; Kumar A
Expert Rev Endocrinol Metab; 2016 Mar; 11(2):103-111. PubMed ID: 30058868
[TBL] [Abstract][Full Text] [Related]
17. [The impact of «faster aspart» on blood glucose control in children and adolescents with type 1 diabetes treated using a sensor-augmented insulin pump].
González de Buitrago Amigo J; González García A; Díaz Fernández P; Fernández Llamas M; Tejado Bravo ML; de Nicolás Jiménez JM; Ferrer Lozano M
An Pediatr (Engl Ed); 2020 Dec; ():. PubMed ID: 33384245
[TBL] [Abstract][Full Text] [Related]
18. Investigating the Association Between Baseline Characteristics (HbA1c and Body Mass Index) and Clinical Outcomes of Fast-Acting Insulin Aspart in People with Diabetes: A Post Hoc Analysis.
Bowering K; Rodbard HW; Russell-Jones D; Bode B; Harris S; Piletic M; Heller S; Woo V; Babu V; Dethlefsen C; Mathieu C
Diabetes Ther; 2019 Feb; 10(1):177-188. PubMed ID: 30547388
[TBL] [Abstract][Full Text] [Related]
19. Insulin aspart: rapid control for postmeal glucose excursions.
Christiansen JS
Expert Rev Endocrinol Metab; 2007 Sep; 2(5):587-597. PubMed ID: 30736121
[TBL] [Abstract][Full Text] [Related]
20. Premixed insulin analogues for the treatment of diabetes mellitus.
Garber AJ
Drugs; 2006; 66(1):31-49. PubMed ID: 16398567
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
